Dresden, Germany
Altavo, known as "The Artificial Voice Company," is a promising medical device startup founded in 2021 and headquartered in Dresden, Germany. The company's primary mission is to empower voiceless individuals by providing them with an individualized, natural-sounding voice. This ambition is underpinned by cutting-edge machine learning and sensor technologies.
Currently, Altavo is targeting patients who have undergone a laryngectomy due to tumor surgery. However, its technology holds potential for broader applications in both speech rehabilitation and other fields outside the medical sector. The founding team comprises experts from diverse backgrounds, including medical device development, artificial intelligence, and linguistics.
With a robust foundation in Health Care, Manufacturing, and Medical Devices industries, Altavo has secured a €5.00M Series A investment in early 2024, backed by investors such as Occident, TGFS - Technologiegründerfonds Sachsen, and Novalis Biotech, indicating strong confidence in its innovative approach and market potential.
